These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31009537)

  • 1. Attitudes and Perceptions Toward Authorized Deception: A Pilot Comparison of Healthy Controls and Fibromyalgia Patients.
    Goo SJ; Frangos E; Richards EA; Ceko M; Justement BL; Korb P; Walitt BT; Colloca L; Bushnell MC
    Pain Med; 2020 Apr; 21(4):794-802. PubMed ID: 31009537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion of authorized deception in the informed consent process does not affect the magnitude of the placebo effect for experimentally induced pain.
    Martin AL; Katz J
    Pain; 2010 May; 149(2):208-215. PubMed ID: 20172652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of Deceptive and Non-Deceptive Placebo Analgesia: Efficacy and Ethical Consequences.
    Mundt JM; Roditi D; Robinson ME
    Ann Behav Med; 2017 Apr; 51(2):307-315. PubMed ID: 27995547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower Placebo Responses After Long-Term Exposure to Fibromyalgia Pain.
    Kosek E; Rosen A; Carville S; Choy E; Gracely RH; Marcus H; Petzke F; Ingvar M; Jensen KB
    J Pain; 2017 Jul; 18(7):835-843. PubMed ID: 28279705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo use in pain management: The role of medical context, treatment efficacy, and deception in determining placebo acceptability.
    Kisaalita N; Staud R; Hurley R; Robinson M
    Pain; 2014 Dec; 155(12):2638-2645. PubMed ID: 25267208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous pain modulation in response to exercise in patients with rheumatoid arthritis, patients with chronic fatigue syndrome and comorbid fibromyalgia, and healthy controls: a double-blind randomized controlled trial.
    Meeus M; Hermans L; Ickmans K; Struyf F; Van Cauwenbergh D; Bronckaerts L; De Clerck LS; Moorken G; Hans G; Grosemans S; Nijs J
    Pain Pract; 2015 Feb; 15(2):98-106. PubMed ID: 24528544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considering the case for an antidepressant drug trial involving temporary deception: a qualitative enquiry of potential participants.
    Dowrick CF; Hughes JG; Hiscock JJ; Wigglesworth M; Walley TJ
    BMC Health Serv Res; 2007 Apr; 7():64. PubMed ID: 17470280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the rationale more important than deception? A randomized controlled trial of open-label placebo analgesia.
    Locher C; Frey Nascimento A; Kirsch I; Kossowsky J; Meyer A; Gaab J
    Pain; 2017 Dec; 158(12):2320-2328. PubMed ID: 28708766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability by parents and children of deception in pediatric research.
    Noel M; Boerner KE; Birnie KA; Caes L; Parker JA; Chambers CT; Fernandez CV; Lee K
    J Dev Behav Pediatr; 2015; 36(2):75-85. PubMed ID: 25650951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting placebo acceptability: deception, outcome, and disease severity.
    Kisaalita NR; Roditi D; Robinson ME
    J Pain; 2011 Aug; 12(8):920-8. PubMed ID: 21816353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of open-label and deceptive placebo analgesia in a healthy sample.
    Disley N; Kola-Palmer S; Retzler C
    J Psychosom Res; 2021 Jan; 140():110298. PubMed ID: 33227553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placebo Use in Pain Management: A Mechanism-Based Educational Intervention Enhances Placebo Treatment Acceptability.
    Kisaalita NR; Hurley RW; Staud R; Robinson ME
    J Pain; 2016 Feb; 17(2):257-69. PubMed ID: 26604097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo Effects and Informed Consent.
    Alfano M
    Am J Bioeth; 2015; 15(10):3-12. PubMed ID: 26479091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient attitudes about the clinical use of placebo: qualitative perspectives from a telephone survey.
    Ortiz R; Chandros Hull S; Colloca L
    BMJ Open; 2016 Apr; 6(4):e011012. PubMed ID: 27044586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiepileptic drugs for chronic non-cancer pain in children and adolescents.
    Cooper TE; Wiffen PJ; Heathcote LC; Clinch J; Howard R; Krane E; Lord SM; Sethna N; Schechter N; Wood C
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012536. PubMed ID: 28779491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Authorized Concealment and Authorized Deception: Well-Intended Secrets Are Likely to Induce Nocebo Effects.
    Blease C
    Am J Bioeth; 2015; 15(10):23-5. PubMed ID: 26479097
    [No Abstract]   [Full Text] [Related]  

  • 17. Deceptive but not open label placebos attenuate motion-induced nausea.
    Barnes K; Yu A; Josupeit J; Colagiuri B
    J Psychosom Res; 2019 Oct; 125():109808. PubMed ID: 31426018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxycodone for neuropathic pain and fibromyalgia in adults.
    Gaskell H; Moore RA; Derry S; Stannard C
    Cochrane Database Syst Rev; 2014 Jun; (6):CD010692. PubMed ID: 24956205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placebo acceptability in chronic pain patients: More dependent on application mode and resulting condition than on individual factors.
    Wolter T; Kleinmann B
    PLoS One; 2018; 13(11):e0206968. PubMed ID: 30399194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adults.
    Chandran A; Schaefer C; Ryan K; Baik R; McNett M; Zlateva G
    J Manag Care Pharm; 2012; 18(6):415-26. PubMed ID: 22839682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.